Laboratorija - BIOHEMIJSKI TUMOR-MARKERI BIOCHEMICAL TUMOUR-MARKERS *srb* Tumorski markeri su specifični biomolekuli koje stvara organizam kao metabolički ili imunološki odgovor zdrave ćelije na prisutnost maligne ćelije ili ih produkuju same maligne ...
Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles: Molecular Therapy - Methods & Clinical Development
Pan-cancer single-cell landscape of tumor-infiltrating T cells | Science
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect
Frontiers | Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis
Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer | ACS Pharmacology & Translational Science
Frontiers | Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
Cancers | Free Full-Text | Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect
Hemato | Free Full-Text | Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study. - Abstract - Europe PMC
Frontiers | IDO Expression in Cancer: Different Compartment, Different Functionality?
Tracing tumorigenesis in a solid tumor model at single-cell resolution | Nature Communications
Clinical Utility of Tumor Markers
:max_bytes(150000):strip_icc()/cancer-antigen-2729-430607-Final-b8a7e5951fbc46c6ac049816b15f9d0e.jpg "Cancer Antigen 27.29 Test: Uses, Procedure, Results")
Cancer Antigen 27.29 Test: Uses, Procedure, Results
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population | Nature Communications
Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies: Trends in Cancer
Frontiers | C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy - eBioMedicine
Frontiers | Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific Reports
Prostate cancer - Wikipedia
Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression | Nature Communications
Cancers | Free Full-Text | CA125 and Ovarian Cancer: A Comprehensive Review
